Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Tg Therapeuticscmn (NASDAQ: TGTX)

$12.05 USD $0.15 (1.26%)
Last Price $12.05
Net Change $0.15 (1.26%)
Bid $0
Ask Price $0
Open Price $11.9
Previous Close Price $11.9
High Price $12.55
Low Price $11.8
Number of Trades 3,962
Volume 1,266,500
Fifty Two Week High $15.05 (2017-03-16)
Fifty Two Week Low $4.1 (2017-01-24)
Average Daily Volume 1,752,435
Share Outstanding 66,780 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $-14.5
Recent Earnings $
Annual EPS $-1.83
Last Quarter EPS $
Market Capitalization $0.80B
Insider Shareholders % 0.19%
Annual Revenue $0B
No. Shares Outstanding 66,780
Inst. Shareholder % 46.25%
Annual Net Income $-0.09B
TTM Net Profit Margin $-57581.25
1-Year Return 55.89%
3-Year Return 95.62%
5-Year Return 85.38%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -14.5%
Dividends per Share $
Stock Split Ratio 1-56
Beta 0.99
TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various B-cell proliferative disorders including lymphoma, leukemia, and auto-immune diseases. TG Therapeutics, Inc., formerly known as Manhattan Pharmaceuticals, Inc., is based in New York.